CRWE, Crown Equity Holdings Inc., CRWE.OB
CRWE is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.
CRWE is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.
CRWE recently reported that it is expanding its business by opening another office in Pakistan. This office will be located in the city of Attock, Pakistan.
More about CRWE at www.crownequityholdings.com.
Penn West Energy Trust (NYSE:PWE) recently has priced a proposed offering of senior unsecured notes to be issued by Penn West Petroleum Ltd., a wholly-owned subsidiary and administrator of the Trust ("Penn West"), on a private placement basis in the United States and Canada (the "Private Placement") with an aggregate principal amount of approximately US$230 million.
The notes to be issued pursuant to the Private Placement are subject to various terms with an average term of approximately 11 years and an average rate of approximately 4.99 percent. The notes issued pursuant to the Private Placement will be unsecured and rank equally with Penn West's bank facilities and Penn West's other outstanding senior notes. Subject to the completion of customary closing conditions, the Private Placement is expected to close on or about December 2, 2010, with funding to occur on or about December 2, 2010 and January 4, 2011. Penn West intends to use the proceeds of the Private Placement to repay advances on its bank facility.
Penn West Energy Trust, an open-end investment trust, engages in acquiring, exploring, developing, exploiting, and holding interests in petroleum and natural gas properties and assets.
Ellington Financial LLC Common (NYSE:EFC) recently reported its financial results for the quarter ended September 30, 2010.
EFC raised approximately $95.0 million of net proceeds through the completion of its initial public offering of common shares that closed on October 14, 2010.Net increase in shareholders' equity resulting from operations for the third quarter was $16.0 million. Basic and diluted earnings per share was $1.30.Book value per share as of September 30, 2010 was $25.78, as compared to $24.56 as of June 30, 2010.Total return for the third quarter was 5.58% (non-annualized). Furthermore, EFC reported a quarterly dividend for the third quarter of $0.80 per share payable December 15, 2010, to shareholders of record December 1, 2010.
Ellington Financial LLC is a specialty finance company formed in August 2007 that specializes in acquiring and managing mortgage-related assets. Ellington Financial LLC based in United States.
Pitney Bowes Inc. (NYSE:PBI) reported recently the opening of the Pitney Bowes Federal Litigation Support Center (FLSC) in downtown Washington, DC, to provide quicker turnaround on litigation support projects to the federal marketplace.
The Pitney Bowes FLSC is capable of processing electronic discovery data to a reviewable format and converting paper documents to digital images. “Along with our National Processing Center in Grand Rapids, Michigan, Pitney Bowes provides more than 30 years of intellectual capital and litigation support expertise to our federal government clients,” said Elizabeth Trumbull, global product manager, PBGS. “Having processed well over 4,000 projects for our clients, we are fully capable of handling matters of any size and complexity.”
Pitney Bowes Inc. provides mail processing equipment and integrated mail solutions in the United States and internationally. It offers a suite of equipment, supplies, software, and services for end-to-end mailstream solutions, which enable its customers to optimize the flow of physical and electronic mail, documents, and packages across their operations.
PWRM, Power 3 Medical Products Inc., PWRM.OB
PWRM is a leading edge biotechnology company engaged in the early detection, monitoring, and targeting of diseases through the analysis of proteins. This dynamic team utilizes proteomics in the discovery of protein biomarkers, drug pathways, and mechanisms of disease.
PWRM's business focus is the development of commercial applications for their proprietary technologies. The scientific team is on the leading edge of the proteomics industry through their discovery of protein footprints, pathways, and mechanisms of disease. These discoveries are being used to develop screening and diagnostic tests for the early detection and treatment of disease. The protein biomarkers, drug targets, and diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer, neurodegenerative disease and drug resistance in cancer.
The Company is in a strong competitive position with over 190 identified biomarkers and a state-of-the-art proteomics laboratory.
PWRM's current IP portfolio offers potential revenue sources in the following areas:
- IP licensing to diagnostic companies engaged in the development of early detection/screening tests
- IP licensing to pharmaceutical companies engaged in drug targeting
- Biomarker Sales
- Exclusive Laboratory Analysis Agreements
More about PWRM at www.Power3Medical.com
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services from Power 3 Medical Products Inc. (OTC:PWRM).